Company profile
ONL Therapeutics
Helping patients see the future
- Industry
- Biotechnology Research
- Employees
- 37
- Headquarters
- Ann Arbor, Michigan
- Founded
- 2011
- LinkedIn followers
- 4,534
- Office locations
- 1
ONL Therapeutics company summary
ONL Therapeutics is a company in the Biotechnology Research industry, headquartered in Ann Arbor, Michigan, founded in 2011. On LinkedIn the company has around 37 employees and 4,534 followers. Its listed specialties include Ophthalmic Drug Development, Glaucoma, Geographic Atrophy, Retinal Detachment.
What technology does ONL Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ONL Therapeutics
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease. By advancing a breakthrough technology designed to protect key retinal cells from Fas-mediated cell death, ONL is pioneering a new approach to preserving vision. ONL is developing a platform of products for use in a range of blinding diseases, including age-related macular degeneration, retinal detachment, glaucoma, and inherited retinal disease.
Specialties
Where is ONL Therapeutics located?
ONL Therapeutics lists 1 location.
Compare companies similar to ONL Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ONL Therapeutics onltherapeutics.com | Biotechnology Research | 37 | 2011 | Ann Arbor, Michigan |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ONL Therapeutics
What does ONL Therapeutics do?
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease. By advancing a breakthrough technology designed to protect key retinal cells from Fas-mediated cell death, ONL is pioneering a new approach to preserving vision. ONL is developing a platform of products for use in a range of blinding diseases, including age-related macular degeneration, retinal detachment, glaucoma, and inherited retinal disease.
How many employees does ONL Therapeutics have?
ONL Therapeutics has around 37 employees on LinkedIn.
Where is ONL Therapeutics headquartered?
ONL Therapeutics is headquartered in Ann Arbor, Michigan.
When was ONL Therapeutics founded?
ONL Therapeutics was founded in 2011.
Build a lead list from companies like ONL Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.